Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Medicine|April 28, 2023
A randomized, active-controlled, parallel, open-label, multicenter, phase 4 study to compare the efficacy and safety of pregabalin sustained release tablet and pregabalin immediate release capsule in type II diabetic patients with peripheral neuropathic painSeon Mee Kang, Jun Hwa Hong, Bon Jeong Ku
Diabetes Research and Clinical Practice|August 13, 2023
Comparison of therapeutic efficacy and safety of sitagliptin, dapagliflozin, or lobeglitazone adjunct therapy in patients with type 2 diabetes mellitus inadequately controlled on sulfonylurea and metformin: Third agent studyJun Hwa Hong, Jun Sung Moon, Kayeon Seong, et al.
Diabetes & Metabolism Journal|May 21, 2020
Deterioration of Sleep Quality According to Glycemic StatusMyung Haeng Hur, Mi-Kyoung Lee, Kayeon Seong, et al.
International Journal of Environmental Research and Public Health|March 11, 2023
Effects of Virtual Reality Exercise Program on Blood Glucose, Body Composition, and Exercise Immersion in Patients with Type 2 DiabetesYu-Jin Lee, Jun-Hwa Hong, Myung-Haeng Hur, et al.
Diabetes, Obesity & Metabolism|April 12, 2023
Comparison of the effects of gemigliptin versus glimepiride on cardiac function in patients with type 2 diabetes uncontrolled with metformin: The gemi-heart studySeung Min Chung, Jun Sung Moon, Jun Hwa Hong, et al.
Journal of Hazardous Materials|July 9, 2026
Accumulation and temporal trends (2002-2023) of legacy and emerging persistent organic pollutants in common dolphins (Delphinus delphis) from Korean coastal watersJun Hwa Hong, Hyeon Ryeong Kim, Sori Mok, et al.
Clinical Endocrinology|May 29, 2016
Implications of oncocytic change in papillary thyroid cancerJun Hwa Hong, Hyon-Seung Yi, Shinae Yi, et al.
Trends in Endocrinology and Metabolism: TEM|May 1, 2022
SGLT-2 inhibitors and GLP-1 receptor agonists in metabolic dysfunction-associated fatty liver diseaseJun Sung Moon, Jun Hwa Hong, Yong Jin Jung, et al.
Biochemical and Biophysical Research Communications|September 11, 2017
PDE 5 inhibitor improves insulin sensitivity by enhancing mitochondrial function in adipocytesHea Min Yu, Hyo Kyun Chung, Koon Soon Kim, et al.
Diabetes Research and Clinical Practice|May 23, 2015
Relationship between hepcidin and GDF15 in anemic patients with type 2 diabetes without overt renal impairmentJun Hwa Hong, Yeon-Kyung Choi, Byong-Keol Min, et al.
Pageof 4